Performance Summary
Past performance is not a reliable indicator of future performance
Source: Internal CI data reports, March 31, 2025
Inception Date: 4 July 2002
*Annualised
$100k Invested Since Inception (net)
Past performance is not a reliable indicator of future performance
Source: Internal CI data reports, March 31, 2025
Risk/Return Since Inception (Per Annum)
“A concentrated mind will pierce a rock” – Japanese Proverb
Quarterly Highlights
- The portfolio was down -8.3% during the quarter, underperforming the S&P/ASX 200 index by -5.5%.1
- Notable underperformers included HMC Capital (HMC), Ryman Healthcare (RYM), DigiCo Infrastructure REIT (DGT), Reece (REH) and Wisetech (WTC).
- Positive contributors included Sigma Healthcare (SIG), Worley (WOR), Mirvac (MGR), SGH (SGH) and Orica (ORI).
¹ Past performance is not a reliable indicator of future performance.
Portfolio Insights & Market Observations
Simply put, too many of our large active weights underperformed and we did not have enough winners.
While in some cases the causes were idiosyncratic (e.g. corporate governance concerns at Wisetech (WTC), we have clearly been too early and aggressive in our entry in several Cyclical exposures. An example is Ryman (RYM), where green shoots in the New Zealand residential real estate cycle (e.g. rising new housing loan commitments) were overwhelmed by a large and dilutive capital raise. While this is disappointing, and it was a large drag on performance, the business is primed to rebound from the “humility” phase with a reset balance sheet and improving industry operating environment ahead. This should significantly improve the growth and return outlook. We articulate our investment proposition in more detail later in the report.
Another case where we have been too early to move is Iluka Resources (ILU). When investing in the Cyclical Subset of Value, we assess Risk-Adjusted Value Latency to be the greatest when the industry is under significant pressure and the stock is priced as such. In practice, signals that we are near a bottom include industry returns being at unsustainably low levels and supply/demand dynamics turning favourable as production is reduced in response to weak price signals. Regarding valuation, we lean into asset-backed multiples given that earnings multiples will tend towards excessive pro-cyclicality. Reflecting on our recent experience, we have learned that it is a better to be a bit late than early. This is particularly so in a market that is increasingly dominated by trending behaviour. Notwithstanding, with industry supply and demand fundamentals, have stabilised, and valuation at only a fraction of book value, we feel that Risk-Adjusted Value Latency is compelling.
After being one of our top contributors in the last quarter, HMC Capital (HMC) pulled back sharply on negative sentiment towards the stock. Among the reasons for this were its exposure to data centres (via 19% ownership of DigiCo Infrastructure REIT), which struggled as a sector as concerns grew that DeepSeek would significantly reduce demand, and linkage to under-pressure private hospital Healthscope via its 23% exposure to HealthCo Healthcare & Wellness REIT (HCW). While the recent issues are unwelcome, from a longer-term perspective, we see several similarities between the HMC platform today and two up-and-coming alternative asset managers ~25 years ago: modern-day global titans, Macquarie and Blackstone. We outlined our investment proposition for HMC in the prior quarterly and retain our conviction in the thesis.
More broadly, while we have been too early in some of our views and too highly exposed in some situations where operating trends have turned adversely, we see significant embedded value latency in the portfolio. Examples where we see scope for material upside include our positions in Ramsay Healthcare (RHC) (structural change, combined with execution, to drive domestic margin improvement), Lendlease (LLC) (restructured business positioned for value creation as real estate cycle recovers from cyclical lows) and our underweight position in banks, where excessive valuations do not appear justified by the subdued operating environment (notably, after significant outperformance in 2024, the banks started to moderate in the quarter).
Observations From The Road
China
In late March we returned to China, which marked our fourth visit in the past 12 months. On our last trip in November, we noted the increased recognition by central authorities of the challenges facing the domestic economy and the impact this has had on both investor and consumer confidence. This was crystalised via the announcement of a raft of stimulus measures focussed on managing further downside risk in residential property, stabilising inflation and improving consumer sentiment over a multi-year period. These measures appear to be having the desired effect with observations across targeted sectors such as automotives (in particular EV’s / PHEV’s), appliances and equipment trade-in and renewal demonstrating real traction. We consider the early signs of stabilisation/improving consumer confidence to be a positive step. We anticipate continued targeted policy responses to manage downside risks to the economy that are less focussed on major direct commodity-linked stimulus along the lines seen post the GFC and 2015/16.
US
We also visited the US, which included several meetings on the gaming sector. Our observations included that both Aristocrat (ALL) and Light & Wonder (LNW) continue to dominate land-based gaming, which is a function of producing the highest quality, most engaging content in the industry. This is supporting relentless market share gains at the expense of smaller competitors. The feedback on Light & Wonder’s recent acquisition of Grover Charitable Gaming was unanimously positive: robust industry structure (e.g. unique market offering, recurring revenue base, long-standing customer relationships) support sustainably high 80-85% margins and LNW has scope to further enhance the offering by rolling out its own content. Other attractive latent opportunities include growing higher-margin direct-to-consumer distribution in the digital business, robust organic growth trends in iGaming (albeit the pace of new state openings has disappointed) and, longer-term, the potential for some of the estimated ~US$500bn in unregulated grey market gross gaming revenue to be legalised. This cocktail of opportunities should drive an attractive multi-year growth story.
Stock In Focus
Ryman Healthcare (RYM)
During the quarter, we increased our investment in Ryman Healthcare (RYM). This reflects increased conviction in Risk-adjusted Value Latency following the February capital raise, which has reset the balance sheet. This provides capacity to continue to drive a change agenda that is focussed on actively releasing capital from existing stock and execute on business improvement initiatives that will return the business to disciplined growth in the coming years.
As a reminder, Ryman develops, owns and operates retirement villages in NZ and Victoria. It is currently experiencing its own “Hubris-to-Humility” cycle, with the exceptional 23% compounded total shareholder return delivered in the 20 years to February 2020 followed by an over 80% decline as rising inflation and twelve consecutive increases in the New Zealand cash rate creating an extremely challenging housing and economic cycle. This cycle has exposed fragilities in, and an overextension of, the business model under prior management.
The company has since made significant changes, including a substantial Board refresh led by a highly regarded Chair in Dean Hamilton. This has included a broad management overhaul (e.g. CEO, CFO, Australia CEO), increased conservatism in company accounting (e.g. extended Deferred Management Fee (DMF) tenure, reducing capitalised interest, revenue recognition changes), a progressive wind-down of their large in-house development team, a planned material reduction in corporate overheads and a more sensible pricing structure (moving from below peers to in-line with peers).
These changes are positioning Ryman for a return to the value creation experienced for the 20 years prior to 2020. While this will take time to become apparent, the value latency embedded in the business is now significant.
The unique nature of the business model in New Zealand, in which a resident pays Ryman the “right” to occupy the unit (and gets this quantum back minus the DMF upon exit), acts as a form of near free-funding for retirement operators who retain an economic exposure to existing units and are able to build additional units (exposure to units) with little to no net funding requirement from the operator.
With the stock trading at 0.6x NTA, you are paying ~60% of the value for the existing unit and land base, while getting future growth for free. As the charts below highlight, this is a dynamic that we have not seen in Ryman historically, creating a rare opportunity.
Chart 1: Ryman – P/NTA over time
Source: Factset, RYM company filings
Chart 2: Ryman – NTA over time2
Source: RYM company filings
2 March-25 NTA of ~$4.6ps based on last 1H25 reported NTA adjusted for February capital raise and the impact of accounting changes expected in the 2H
Further, operating and industry trends are now positive.
For example, New Zealand housing market turnover is showing early signs of improvement following 30-year lows in activity levels (important given residents need to sell their house to move into a RYM village).
Chart 3: NZ Quarterly turnover of houses (12mth rolling sum, as a % of dwelling stock)
Source: StatsNZ
House prices have stabilised after going through the largest correction in 30 years.
Chart 4: NZ house prices YoY
Source: REINZ house price index, UBS, CI estimates
Industry-wide approvals for new retirement units have fallen ~50% in the past 18 months.
Chart 5: Retirement Villages Consents (12m rolling)
Source: Source Stats NZ, CI estimates
Finally, long-term demographic trends remain supportive of future growth, with Ryman’s average age-of-entry into an independent villa being 83 and serviced apartment 87.
Chart 6: Incremental population of 85+ year olds in NZ
Source: Macrobond
Portfolio Snapshot
Past performance is not a reliable indicator of future performance
Source: Internal CI data reports, March 31, 2025
Top 5 Fund Holdings
name | sector | subset |
---|---|---|
BHP Group Ltd | Materials | Cyclicals |
CSL Limited | Health Care | Growth |
National Australia Bank Limited | Financials | Stalwarts |
Macquarie Group Ltd | Financials | Stalwarts |
ANZ Group Holdings Limited | Financials | Stalwarts |
Sector Exposure
Subsets of Value
Market Capitalisation
Since Inception Net Returns in Up/Down Markets
Portfolio & Risk Metrics
Portfolio | Benchmark | |
---|---|---|
Price/Earnings | ||
Yield | ||
Price/Book | ||
Net Debt to Equity | ||
FCF Yield FS | ||
Forecast Earnings Growth | ||
Return on Equity | ||
Tracking Error | ||
Beta |
Further Information
Looking for further information regarding the Fund, please don’t hesitate to get in touch:
